Enlicitide Trial: 60% LDL Cut in New Cholesterol Pill | AcademicJobs
Explore the Enlicitide trial results showing 60% LDL reduction in high-risk patients. Academic insights from UT Southwestern on this game-changing oral therapy for cardiovascular health.
research-publication-newscardiovascular-researchcholesterol-management

